Medikaloka Hermina Tbk PT
IDX:HEAL
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Johnson & Johnson
NYSE:JNJ
|
US |
|
Berkshire Hathaway Inc
NYSE:BRK.A
|
US |
|
Bank of America Corp
NYSE:BAC
|
US |
|
Mastercard Inc
NYSE:MA
|
US |
|
UnitedHealth Group Inc
NYSE:UNH
|
US |
|
Exxon Mobil Corp
NYSE:XOM
|
US |
|
Pfizer Inc
NYSE:PFE
|
US |
|
Nike Inc
NYSE:NKE
|
US |
|
Visa Inc
NYSE:V
|
US |
|
Alibaba Group Holding Ltd
NYSE:BABA
|
CN |
|
JPMorgan Chase & Co
NYSE:JPM
|
US |
|
Coca-Cola Co
NYSE:KO
|
US |
|
Verizon Communications Inc
NYSE:VZ
|
US |
|
Chevron Corp
NYSE:CVX
|
US |
|
Walt Disney Co
NYSE:DIS
|
US |
|
PayPal Holdings Inc
NASDAQ:PYPL
|
US |
P/OCF
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Price to Operating Cash Flow (P/OCF) ratio compares a company`s market value to the cash it generates from its core operations.
Valuation Scenarios
If P/OCF returns to its 3-Year Average (18.3), the stock would be worth Rp1 238.77 (6% upside from current price).
| Scenario | P/OCF Value | Implied Price | Upside/Downside |
|---|---|---|---|
| Current Multiple | 17.2 | Rp1 170 |
0%
|
| 3-Year Average | 18.3 | Rp1 238.77 |
+6%
|
| 5-Year Average | 17.3 | Rp1 174.23 |
+0%
|
| Industry Average | 17.8 | Rp1 208.57 |
+3%
|
| Country Average | 7.9 | Rp538.51 |
-54%
|
Forward P/OCF
Today’s price vs future operating cash flow
Peer Comparison
| Market Cap | P/OCF | P/E | ||||
|---|---|---|---|---|---|---|
| ID |
|
Medikaloka Hermina Tbk PT
IDX:HEAL
|
18T IDR | 17.2 | 42.4 | |
| US |
|
HCA Healthcare Inc
NYSE:HCA
|
96.6B USD | 7.4 | 14.2 | |
| SA |
|
Dr Sulaiman Al-Habib Medical Services Group Co
SAU:4013
|
98B SAR | 28.8 | 40.8 | |
| ZA |
N
|
Netcare Ltd
JSE:NTC
|
23.2B ZAR | 9.5 | 13.8 | |
| MY |
I
|
IHH Healthcare Bhd
KLSE:IHH
|
77.8B MYR | 14 | 37.1 | |
| ZA |
L
|
Life Healthcare Group Holdings Ltd
JSE:LHC
|
17.5B ZAR | 3.5 | 4.5 | |
| BR |
|
Rede D'Or Sao Luiz SA
BOVESPA:RDOR3
|
84.8B BRL | 155.9 | 17.9 | |
| US |
|
Tenet Healthcare Corp
NYSE:THC
|
15.4B USD | 4.4 | 11 | |
| CN |
A
|
Aier Eye Hospital Group Co Ltd
SZSE:300015
|
103.3B CNY | 17.6 | 30.7 | |
| IN |
|
Apollo Hospitals Enterprise Ltd
NSE:APOLLOHOSP
|
1.1T INR | 31.9 | 61.3 | |
| US |
|
Ensign Group Inc
NASDAQ:ENSG
|
10.9B USD | 19.2 | 31.4 |
Market Distribution
| Min | 0 |
| 30th Percentile | 5.1 |
| Median | 7.9 |
| 70th Percentile | 16.8 |
| Max | 294 565.7 |
Other Multiples
Medikaloka Hermina Tbk PT
Glance View
Medikaloka Hermina Tbk PT, commonly known as Hermina, has carved a significant niche in Indonesia's healthcare sector, evolving from its humble beginnings into a formidable operator of private hospitals. Founded in 1985, Hermina began as a maternity hospital in Jakarta, and over the decades, it deftly expanded its network to become the largest private hospital operator in the country by bed capacity. Central to Hermina’s growth strategy has been its focus on providing comprehensive women's and children's healthcare services, all while scaling up to offer general medical services, which attract a diverse patient demographic. The company's growth is underscored by its strategic location choices, placing hospitals in areas with significant population density, thus ensuring a steady influx of patients. Hermina generates revenue by offering a wide range of services, from inpatient and outpatient care to specialized medical treatments and surgeries. A significant portion of their income is driven by the robust maternity and pediatric services, which holds a strong customer loyalty due to decades of trusted service. Furthermore, Hermina has successfully navigated the complexities of Indonesia's healthcare insurance landscape, integrating both public health insurance plans and private offerings, widening their accessibility and market reach. This balanced approach helps sustain their profit margins in a competitive environment where healthcare access is rapidly evolving. Their commitment to expanding service offerings and maintaining high standards of medical care while adapting to digital health trends continues to position them as a leader in the Indonesian healthcare market.